ASAnna Linnea Södergren

Anna Linnea Södergren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna Linnea Södergren has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Sofia Ramström

    Department of Clinical Chemistry and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

    6 shared publications
  • Nahreen Tynngård

    Department of Clinical Immunology and Transfusion Medicine, Linköping University, Linköping, Sweden

    3 shared publications
  • Ann-Charlotte B. Svensson Holm

    A Department of Clinical and Experimental Medicine, Faculty of Health Sciences , Linköping University , Linköping , Sweden

    1 shared publication
  • Eva G. Lindström

    B Department of Medical and Health Sciences, Faculty of Health Sciences , Linköping University , Linköping , Sweden , and

    1 shared publication
  • G. Berlin

    Department of Clinical Immunology and Transfusion Medicine, and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

    1 shared publication
  • Karin Öllinger

    A Department of Clinical and Experimental Medicine, Faculty of Health Sciences , Linköping University , Linköping , Sweden

    1 shared publication

Latest Publications

  • Open Access

    Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol

    by Anna Linnea Södergren, Sofia Ramström

    It is recognised that platelets respond differently to activation, where a subpopulation of platelets adopt a procoagulant phenotype while others are aggregatory. However, it has not been thoroughly tested whether these subpopulations will remain in maximally activated samples, or if they are merely a result of different platelet sensitivities to agonist activation. Here platelets were activated with gradually increasing concentrations of thrombin and/or the GPVI agonist cross-linked collagen-related peptide (CRP-XL). Platelet activation was investigated using a novel six-colour flow cytometry protocol evaluating exposure of phosphatidylserine, active conformation of the fibrinogen receptor αIIbβ3, α-granule and lysosomal release (P-selectin and LAMP-1 exposure), mitochondrial membrane integrity and platelet fragmentation. Upon activation by CRP-XL or thrombin+CRP-XL, platelets formed three differently sized subpopulations. Normal-sized platelets showed high exposure of aggregatory active αIIbβ3 and intact mitochondria, while the smaller platelets and platelet fragments showed high exposure of procoagulant phosphatidylserine. The distribution of platelets between the differently sized subpopulations remained stable despite high agonist concentrations. All three were still present after 30 and 60 min of activation, showing that all platelets will not have the same characteristics even after maximal stimulation. This suggests that platelet subpopulations with distinct activation patterns exist within the total platelet population.


  • Detection of Lysosomal Exocytosis in Platelets by Flow Cytometry

    by Anna L. Södergren, Sofia Ramström

    Flow cytometry is a method that allows high throughput analysis of individual cells in suspension. By inclusion of fluorescently labelled antibodies, it is possible to analyze the abundance of one or more surface antigens, such as LAMP-1, without prior lysis of cells. Here we describe the special considerations required for the investigation of lysosomal exocytosis from platelets analyzed with flow cytometry.


  • Platelet Function Determined by Flow Cytometry: New Perspectives?

    by Anna L. Södergren, Nahreen Tynngård, Tomas L. Lindahl, Sofia Ramström

    Flow cytometry enables studies of several different aspects of platelet function in response to a variety of platelet agonists. This can be done using only a small volume of whole blood, and also in blood with low platelet counts. These properties, together with the increasing number of flow cytometers available in hospitals worldwide, make flow cytometry an interesting option for laboratories interested in studies of platelet function in different clinical settings. This review focuses on practical issues regarding the use of flow cytometry for platelet function testing. It provides an overview of available activation markers, platelet agonists, and experimental setup issues. The review summarizes previous experience and factors important to consider to perform high-quality platelet function testing by flow cytometry. It also discusses its current use and possibilities and challenges for future use of flow cytometry in clinical settings.


  • Responsiveness of platelets during storage studied with flow cytometry – formation of platelet subpopulations and LAMP‐1 as new markers for the platelet storage lesion

    by A. L. Södergren, N. Tynngård, G. Berlin, S. Ramström

    Background and Objectives: Storage lesions may prevent transfused platelets to respond to agonists and arrest bleeding. The aim of this study was to evaluate and quantify the capacity of platelet activation during storage using flow cytometry and new markers of platelet activation.Materials and Methods: Activation responses of platelets prepared by apheresis were measured on days 1, 5, 7 and 12. In addition, comparisons were made for platelet concentrates stored until swirling was affected. Lysosome‐associated membrane protein‐1 (LAMP‐1), P‐selectin and phosphatidylserine (PS) exposure were assessed by flow cytometry on platelets in different subpopulations in resting state or following stimulation with platelet agonists (cross‐linked collagen‐related peptide (CRP‐XL), PAR1‐ and PAR4‐activating peptides).Results: The ability to form subpopulations upon activation was significantly decreased already at day 5 for some agonist combinations. The agonist‐induced exposure of PS and LAMP‐1 also gradually decreased with time. Spontaneous exposure of P‐selectin and PS increased with time, while spontaneous LAMP‐1 exposure was unchanged. In addition, agonist‐induced LAMP‐1 expression clearly discriminated platelet concentrates with reduced swirling from those with retained swirling. This suggests that LAMP‐1 could be a good marker to capture changes in activation capacity in stored platelets.Conclusion: The platelet activation potential seen as LAMP‐1 exposure and fragmentation into platelet subpopulations is potential sensitive markers for the platelet storage lesion.


  • Thrombin-induced lysosomal exocytosis in human platelets is dependent on secondary activation by ADP and regulated by endothelial-derived substances

    by Anna L. Södergren, Ann-Charlotte B. Svensson Holm, Sofia Ramström, Eva G. Lindström, Magnus Grenegård, Karin Öllinger

    Exocytosis of lysosomal contents from platelets has been speculated to participate in clearance of thrombi and vessel wall remodelling. The mechanisms that regulate lysosomal exocytosis in platelets are, however, still unclear. The aim of this study was to identify the pathways underlying platelet lysosomal secretion and elucidate how this process is controlled by platelet inhibitors. We found that high concentrations of thrombin induced partial lysosomal exocytosis as assessed by analysis of the activity of released N-acetyl-β-glucosaminidase (NAG) and by identifying the fraction of platelets exposing the lysosomal-associated membrane protein (LAMP)-1 on the cell surface by flow cytometry. Stimulation of thrombin receptors PAR1 or PAR4 with specific peptides was equally effective in inducing LAMP-1 surface expression. Notably, lysosomal exocytosis in response to thrombin was significantly reduced if the secondary activation by ADP was inhibited by the P2Y12 antagonist cangrelor, while inhibition of thromboxane A2 formation by treatment with acetylsalicylic acid was of minor importance in this regard. Moreover, the NO-releasing drug S-nitroso-N-acetyl penicillamine (SNAP) or the cyclic AMP-elevating eicosanoid prostaglandin I2 (PGI2) significantly suppressed lysosomal exocytosis. We conclude that platelet inhibitors that mimic functional endothelium such as PGI2 or NO efficiently counteract lysosomal exocytosis. Furthermore, we suggest that secondary release of ADP and concomitant signaling via PAR1/4- and P2Y12 receptors is important for efficient platelet lysosomal exocytosis by thrombin.


  • Platelet adhesion changes during storage studied with a novel method using flow cytometry and protein-coated beads

    by Nahreen Tynngård, Maria Wallstedt, Anna L. Södergren, Lars Faxälv, Sofia Ramström

    The aim of the present study was to set up and evaluate a novel method for studies of platelet adhesion and activation in blood and platelet suspensions such as platelet concentrate (PC) samples using protein-coated polystyrene beads and flow cytometry. To demonstrate its usefulness, we studied PCs during storage. PCs were prepared by aphaeresis technique (n = 7). Metabolic variables and platelet function was measured on day 1, 5, 7 and 12 of storage. Spontaneous and TRAP-6-induced adhesion to fibrinogen- and collagen-coated beads was analyzed by flow cytometry. P-selectin and phosphatidyl serine (PS) expression was assessed on platelets bound to beads as well as on non-adherent platelets. Platelet adhesion to fibrinogen beads had increased by day 12 and adhesion to collagen beads at day 7 of storage (p < 0.05). TRAP-6 stimulation significantly increased the platelet adhesion to fibrinogen beads (p < 0.05) as well as the P-selectin and PS exposure on platelets bound to beads (p < 0.01) during the first 7 days of storage, but by day 12, significant changes were no longer induced by TRAP-6 stimulation. We demonstrate that our adhesion assay using protein-coated polystyrene beads can be used to assess the adhesion properties of platelets during storage without the addition of red blood cells. Therefore it may offer a useful tool for future studies of platelet adhesive capacity in transfusion medicine and other settings.